Table 1.
Myocardial Infarct phenotype before and after treatment (values determined by cMRI)
| Parameter | Groups | Baseline | Post-MI | Week 2 Post-Inj | Week 8 Post-Inj | p-value |
|---|---|---|---|---|---|---|
| Infarct Size (%LV mass) | CCM | 0 | 24.4±3.2 | 23.5±1.7 | 26.3±1.5 | |
| MSCs | 0 | 24.9±2.4 | 14.5±3.1 | 10.9±5.1 | p=0.002*† | |
| Infarct Volume (ml) | CCM | 0 | 13.4±1.3 | 11.9±1.0 | 13.4±1.0 | p=0.009* |
| MSCs | 0 | 11.7±1.7 | 7.7±1.8† | 7.3±3.5† | p≤0.001† | |
| LV mass (g) | CCM | 51.2±3.3 | 51.2±3.3 | 51.7±5.0 | 51.5±6.0 | |
| MSCs | 45.9±3.6 | 45.9±3.6 | 51.2±4.2 | 62.1±5.4 | p=NS | |
| Circumferential Extent of MI (%LV) | CCM | 0 | 41.5±5.0 | 44.8±2.4 | 38.04±4.3 | |
| MSCs | 0 | 38.8±4.0 | 27.8±6.5 | 27.6±12.1 | p=NS | |
| End-Diastolic Volume (ml) | CCM | 33.2±3.4 | 38.8±4.0 | 43.0±4.8 | 40.5±1.2 | |
| MSCs | 32.2±2.4 | 34.2±3.8 | 41.0±4.7 | 46.5±10.7 | p=NS | |
| End-Systolic Volume (ml) | CCM | 20.3±2.3 | 28.9±3.6 | 30.8±4.1 | 28.2±0.9 | |
| MSCs | 20.1±1.6 | 24.5±2.6 | 26.7±5.1 | 31.4±11.3 | p=NS | |
| Stroke Volume (ml) | CCM | 12.9±1.3 | 9.8±1.1 | 12.2±0.8 | 12.2±0.3 | p= 0.003† |
| MSCs | 12.1±1.0 | 9.7±1.3 | 14.3±1.4□ | 15.1±1.1† | p=0.005□ | |
| Heart Rate | CCM | 86.2±6.8 | 82.2±3.0 | 69.1±1.5 | 81.1±19.5 | |
| MSCs | 102.5±9.0 | 85.7±4.3 | 81.0±5.5 | 84.1±17.3 | p=NS | |
| Ejection Fraction | CCM | 39.1±1.6 | 25.8±3.1 | 29.1±1.4 | 30.2±0.4 | p=0.042□ |
| MSCs | 37.8±1.6 | 27.9±1.1 | 37.0±5.0□ | 36.4±9.4† | p=0.026† |
indicates p values significant between groups
indicate p values significant within group
indicate p values significant within group